• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arterioscler Thromb Vasc Biol . COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical, and Translational Research Questions

tetano

Editor, Senior Moderator
Arterioscler Thromb Vasc Biol


. 2020 Sep 22;ATVBAHA120314515.
doi: 10.1161/ATVBAHA.120.314515. Online ahead of print.
COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical, and Translational Research Questions


Shari B Brosnahan[SUP] 1 [/SUP], Annemijn H Jonkman[SUP] 2 3 [/SUP], Matthias C Kugler[SUP] 1 [/SUP], John S Munger[SUP] 1 [/SUP], David A Kaufman[SUP] 1 [/SUP]



Affiliations

Abstract

The severe acute respiratory syndrome coronavirus-2 emerged as a serious human pathogen in late 2019, causing the disease coronavirus disease 2019 (COVID-19). The most common clinical presentation of severe COVID-19 is acute respiratory failure consistent with the acute respiratory distress syndrome. Airway, lung parenchymal, pulmonary vascular, and respiratory neuromuscular disorders all feature in COVID-19. This article reviews what is known about the effects of severe acute respiratory syndrome coronavirus-2 infection on different parts of the respiratory system, clues to understanding the underlying biology of respiratory disease, and highlights current and future translation and clinical research questions.

Keywords: COVID-19; diaphragm; infection; respiratory system; thromboembolism.
 
Back
Top Bottom